Mediwound Stock Probability of Future Stock Price Finishing Under 8.23

MDWD Stock  USD 16.90  0.43  2.48%   
Mediwound's future price is the expected price of Mediwound instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Mediwound performance during a given time horizon utilizing its historical volatility. Check out Mediwound Backtesting, Mediwound Valuation, Mediwound Correlation, Mediwound Hype Analysis, Mediwound Volatility, Mediwound History as well as Mediwound Performance.
For information on how to trade Mediwound Stock refer to our How to Trade Mediwound Stock guide.
  
The current year's Price Earnings To Growth Ratio is expected to grow to 0.18, whereas Price To Sales Ratio is forecasted to decline to 4.66. Please specify Mediwound's target price for which you would like Mediwound odds to be computed.

Mediwound Target Price Odds to finish below 8.23

The tendency of Mediwound Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to drop to $ 8.23  or more in 90 days
 16.90 90 days 8.23 
near 1
Based on a normal probability distribution, the odds of Mediwound to drop to $ 8.23  or more in 90 days from now is near 1 (This Mediwound probability density function shows the probability of Mediwound Stock to fall within a particular range of prices over 90 days) . Probability of Mediwound price to stay between $ 8.23  and its current price of $16.9 at the end of the 90-day period is about 29.07 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.41 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Mediwound will likely underperform. Additionally Mediwound has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Mediwound Price Density   
       Price  

Predictive Modules for Mediwound

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Mediwound. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Mediwound's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
14.3917.2720.15
Details
Intrinsic
Valuation
LowRealHigh
15.6022.1725.05
Details
4 Analysts
Consensus
LowTargetHigh
25.4828.0031.08
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.49-0.44-0.38
Details

Mediwound Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Mediwound is not an exception. The market had few large corrections towards the Mediwound's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Mediwound, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Mediwound within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.23
β
Beta against Dow Jones1.41
σ
Overall volatility
0.80
Ir
Information ratio -0.06

Mediwound Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Mediwound for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Mediwound can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Mediwound generated a negative expected return over the last 90 days
The company reported the previous year's revenue of 18.69 M. Net Loss for the year was (6.72 M) with profit before overhead, payroll, taxes, and interest of 13.16 M.
Mediwound currently holds about 10.41 M in cash with (10.46 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.31.
Mediwound has a poor financial position based on the latest SEC disclosures
Roughly 20.0% of the company outstanding shares are owned by corporate insiders
Latest headline from seekingalpha.com: MediWound Q3 2024 Earnings Preview

Mediwound Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Mediwound Stock often depends not only on the future outlook of the current and potential Mediwound's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Mediwound's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares OutstandingM
Cash And Short Term Investments41.5 M

Mediwound Technical Analysis

Mediwound's future price can be derived by breaking down and analyzing its technical indicators over time. Mediwound Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Mediwound. In general, you should focus on analyzing Mediwound Stock price patterns and their correlations with different microeconomic environments and drivers.

Mediwound Predictive Forecast Models

Mediwound's time-series forecasting models is one of many Mediwound's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Mediwound's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Mediwound

Checking the ongoing alerts about Mediwound for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Mediwound help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Mediwound generated a negative expected return over the last 90 days
The company reported the previous year's revenue of 18.69 M. Net Loss for the year was (6.72 M) with profit before overhead, payroll, taxes, and interest of 13.16 M.
Mediwound currently holds about 10.41 M in cash with (10.46 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.31.
Mediwound has a poor financial position based on the latest SEC disclosures
Roughly 20.0% of the company outstanding shares are owned by corporate insiders
Latest headline from seekingalpha.com: MediWound Q3 2024 Earnings Preview
When determining whether Mediwound is a strong investment it is important to analyze Mediwound's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Mediwound's future performance. For an informed investment choice regarding Mediwound Stock, refer to the following important reports:
Check out Mediwound Backtesting, Mediwound Valuation, Mediwound Correlation, Mediwound Hype Analysis, Mediwound Volatility, Mediwound History as well as Mediwound Performance.
For information on how to trade Mediwound Stock refer to our How to Trade Mediwound Stock guide.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mediwound. If investors know Mediwound will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mediwound listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.16)
Revenue Per Share
2.18
Quarterly Revenue Growth
0.061
Return On Assets
(0.16)
Return On Equity
(0.76)
The market value of Mediwound is measured differently than its book value, which is the value of Mediwound that is recorded on the company's balance sheet. Investors also form their own opinion of Mediwound's value that differs from its market value or its book value, called intrinsic value, which is Mediwound's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mediwound's market value can be influenced by many factors that don't directly affect Mediwound's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mediwound's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mediwound is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mediwound's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.